Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Angelini nocks an AI arrow with $120M Quiver Bioscience deal

Angelini nocks an AI arrow with $120M Quiver Bioscience deal

  • February 23, 2026

Rome-based Angelini Pharma has inked a multi-year deal with Massachusetts biotech Quiver Bioscience that is designed to advance novel therapies for genetic epilepsies and could garner up to $120 million in milestone payments for the latter.

Leave A Comment

Fields (*) Mark are Required